Stockreport

Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

Celularity Inc. - Class A  (CELU) 
PDF FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-relate [Read more]